Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb)

INTRODUCTION: TheTADAlafil treatment for Fetuses with early-onset growth Restriction: multicentrer, randomizsed, phase II trial (TADAFER II) study showed the possibility of prolonging the pregnancy period in cases of early-onset fetal growth restriction; however, it was an open-label study. To estab...

Descripción completa

Detalles Bibliográficos
Autores principales: Maki, Shintaro, Tanaka, Hiroaki, Takakura, Sho, Nii, Masafumi, Tanaka, Kayo, Ogura, Toru, Kotera, Mayumi, Nishimura, Yuki, Tamaru, Satoshi, Ushida, Takafumi, Tanaka, Yasuhiro, Kikuchi, Norihiko, Kinjo, Tadatsugu, Kawamura, Hiroshi, Takano, Mayumi, Nakamura, Koji, Suga, Sachie, Kasai, Michi, Yasui, Osamu, Nagao, Kenji, Maegawa, Yuka, Kotani, Tomomi, Endo, Masayuki, Yasuhi, Ichiro, Aoki, Shigeru, Aoki, Yoichi, Yoshida, Yoshio, Nakata, Masahiko, Sekizawa, Akihiko, Ikeda, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198796/
https://www.ncbi.nlm.nih.gov/pubmed/35701067
http://dx.doi.org/10.1136/bmjopen-2021-054925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198796/
https://www.ncbi.nlm.nih.gov/pubmed/35701067
http://dx.doi.org/10.1136/bmjopen-2021-054925

Ejemplares similares